The pharmacology of chlormethiazole: A potential neuroprotective agent?

CNS Drug Reviews

Volumn 10, Issue 4, 2004, Pages 281-294

  Wilby, M J ^a   Hutchinson, P J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Chlormethiazole; Neuroprotection; Stroke

Indexed keywords

CLOMETHIAZOLE;

4 AMINOBUTYRIC ACID RELEASE; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; DERIVATIZATION; DRUG EFFECT; DRUG MECHANISM; GERBIL; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIMATE; RAT; RECOGNITION; REVIEW; SEIZURE; STROKE; SURVIVAL TIME;

EID: 12344333481     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2004.tb00028.x     Document Type: Review

References (52)

1. Centerholt C, Ekblom M, Odergren T, et al. Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazole. Eur J Clin Pharmacol 2003;59:117-122.
2. Chaulk D, Wells J, Evans S, Jackson D, Corbett D. Long-term effects of clomethiazole in a model of global ischemia. Exp Neurol 2003;182(2):476-482.
3. Colbourne F, Corbett D. Delayed postischemic hypothermia: A six month survival study using behavioural and histological assessments of neuroprotection. J Neurosci 1995;15(11):7250-7260.
4. Cross AJ, Jones JA, Snares M, Jostell KG, Bredberg U, Green AR. The protective action of chlormethiazole against ischaemia-induced neurodegeneration in gerbils when infused at doses having little sedative or anticonvulsant activity. Br J Pharmacol 1995;114(8):1625-1630.
5. Cross AJ, Jones JA, Baldwin HA, Green AR. Neuroprotective activity of chlormethiazole following transient forebrain ischaemia in the gerbil. Br J Pharmacol 1991;104(2):406-411.
6. Eap CB, Schnyder C, Besson J, Savary L, Buclin T. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers. Clin Pharmacol Ther 1998;64:52-57.
7. A receptor function. Brain Res 2000;884(1-2):31-34.
8. Farooque M, Isaksson J, Jackson DM, Olsson Y. Clomethiazole (ZENDRA, CMZ) improves hind limb motor function and reduces neuronal damage after severe spinal cord injury in rat. Acta Neuropathol (Berl) 1997;98:22-30.
9. Franz M, Dlabal H, Kunz S, Ulferts J, Gruppe H, Gallhofer B. Treatment of alcohol withdrawal: Tiapride and carbamazepine versus clomethiazole. A pilot study. Eur Arch Psychiatry Clin Neurosci 2001;251:185-192.
10. Gent JP, Wacey TA. The effects of chlormethiazole on single unit activity in rat brain: Interactions with inhibitory and excitatory neurotransmitters. Br J Pharmacol 1983;80(3):439-444.
11. Gray PA, Park GR. Chlormethiazole sedation for critically ill patients in renal failure. Anaesthesia 1989;44:913-915.
12. Green AR, Murray TK, Misra A, Snape MF, Jones JA, Cross AJ. The metabolism of clomethiazole in gerbils and the neuroprotective and sedative activity of the metabolites. Br J Pharmacol 2000;129:95-100.
13. Green AR, Cross AJ. Attenuation by chlormethiazole of oedema following focal ischaemia in the cerebral cortex of the rat. Neurosci Lett 1994;173(1-2):27-30.
14. A and glycine receptors by chlormethiazole. Eur J Pharmacol 1992;210(3):239-246.
15. Harmon D, Coleman E, Marshall C, Lan W, Shorten G. The effect of clomethiazole on plasma concentrations of interleukin-6, -8, -1beta, tumor necrosis factor-alpha, and neutrophil adhesion molecule expression during experimental extracorporeal circulation. Anesth Analg 2003;97:13-18.
16. Harvey PK, Higenbottam TW, Loh L. Chlormethiazole in treatment of status epilepticus. Br Med J 1975;2(5971):603-605.
17. Herran A, Vazquez-Barquero JL. Treating alcohol dependence. Chlormethiazole is widely used in Europe. Br Med J 1997;315:1466.
18. Hutchinson PJ, O'Connell MT, Coles JP, et al. Investigation of the effect of chlormethiazole on cerebral chemistry in neurosurgical patients: A combined study of microdialysis and a neuroprotective agent. Br J Clin Pharmacol 2002;53:275-283.
19. Kong RS, Butterworth J, Aveling W, et al. Clinical trial of the neuroprotectant clomethiazole in coronary artery bypass graft surgery: A randomized controlled trial. Anesthesiology 2002;97:585-591.
20. Liang SP, Kanthan R, Shuaib A, Wishart T. Effects of clomethiazole on radial-arm maze performance following global forebrain ischemia in gerbils. Brain Res 1997;751(2):189-195.
21. Lyden P, Jacoby M, Schim J, et al. The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): Final results. Neurology 2001;57:1199-1205.
22. Lyden P, Shuaib A, Ng K, et al. Clomethiazole Acute Stroke Study in ischemic stroke (CLASS-I): Final results. Stroke 2002;33:122-128.
23. Mahoney FI, Barthel DW. Functional evaluation: The Barthel index. Maryland State Med J 1965;14(Feb):61-65.
24. Marshall JW, Cross AJ, Jackson DM, Green AR, Baker HF, Ridley RM. Clomethiazole protects against hemineglect in a primate model of stroke. Brain Res Bull 2000;52:21-29.
25. Marshall JW, Cross AJ, Ridley RM. Functional benefit from clomethiazole treatment after focal cerebral ischemia in a nonhuman primate species. Exp Neurol 1999;156:121-129.
26. Marshall JW, Green AR, Ridley RM. Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures. Brain Res 2003;972:119-126.
27. Mather LE, Runciman WB, Ilsley AH, Thomson KR, Goldin AR. Direct measurement of chlormethiazole extraction by liver, lung and kidney in man. Br J Clin Pharmacol 1981;12(3):319-325.
28. Modig J. Indications of chlormethiazole as a protective agent in experimental endotoxemia. Eur Surg Res 1988;20:195-204.
29. Moody EJ, Skolnick P. Chlormethiazole: Neurochemical actions at the γ-aminobutyric acid receptor complex. Eur J Pharmacol 1989;164(1):153-158.
30. Nimmerrichter AA, Walter H, Gutierrez-Lobos KE, Lesch OM. Double-blind controlled trial of γ-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal. Alcohol 2002;37:67-73.
31. Offen CP, Frearson MJ, Wilson K, Burnett D. 4,5-Dimethylthiazole-N-oxide- S-oxide: A metabolite of chlormethiazole in man. Xenobiotica 1985;15(6):503-511.
32. Ogren SO. Chlormethiazole-mode of action. Acta Psychiatr Scand 1986;329(Suppl):13-27.
33. Pathy MS. A double-blind comparison of chlormethiazole and dichloralphenazone: A sedative/hypnotic in geriatric medicine. Curr Med Res Opin 1974;2:648-656.
34. Pentikainen PJ, Valtonen VV, Miettinen TA. Deaths in connection with chlormethiazole (heminevrin) therapy. Int J Clin Pharmacol Biopharm 1976;14(3):225-230.
35. Ratz AE, Schlienger RG, Linder L, Langewitz W, Haefeli WE. Pharmacokinetics and pharmacodynamics of clomethiazole after oral and rectal administration in healthy subjects. Clin Ther 1999;21:829-840.
36. Scott DB, Beamish D, Hudson IN, Jostell KG. Prolonged infusion of chlormethiazole in intensive care. Br J Anaesth 1980;52:541-545.
37. Seow LT, Mather LE, Cousins MJ. Failure of IV atropine to abolish nasal irritation caused by chlormethiazole infusion in elderly patients undergoing spinal anaesthesia. Anaesth Intensive Care 1984;12:127-130.
38. Seow LT, Mather LE, Cousins MJ. Comparison of the efficacy of chlormethiazole and diazepam as i.v. sedatives for supplementation of extradural anaesthesia. Br J Anaesth 1985;57:747-752.
39. Seow LT, Mather LE, Roberts JG. An integrated study of pharmacokinetics and pharmacodynamics of chlormethiazole in healthy young volunteers. Eur J Clin Pharmacol 1981;19:263-269.
40. Shaw G, Bury RW, Mashford ML, Breen KJ, Desmond PV. Cimetidine impairs the elimination of chlormethiazole. Eur J Clin Pharmacol 1981;21:83-85.
41. Shuaib A, Ijaz S, Kanthan R. Clomethiazole protects the brain in transient forebrain ischemia when used up to 4 h after the insult. Neurosci Lett 1995;197(2):109-112.
42. Simi A, Ingelman-Sundberg M, Tindberg N. Neuroprotective agent chlomethiazole attenuates c-fos, c-jun, and AP-1 activation through inhibition of p38 MAP kinase. J Cereb Blood Flow Metab 2000;20(7):1077-1088.
43. Snape MF, Baldwin HA, Cross AJ, Green AR. The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Neuroscience 1993;53(3):837-844.
44. Stanley TV. Chlormethiazole: An effective oral sedative for cranial CT scans in children. Aust Paediatr J 1985;21:191-192.
45. Sydserff SG, Cross AJ, West KJ, Green AR. The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia. Br J Pharmacol 1995;114(8):1631-1635.
46. Sydserff SG, Cross AJ, Green AR. The neuroprotective effect of chlormethiazole on ischaemic neuronal damage following permanent middle cerebral artery ischaemia in the rat. Neurodegeneration 1995;4(3):323-328.
47. Sydserff SG, Green AR, Cross AJ. The effect of oedema and tissue swelling on the measurement of neuroprotection: A study using chlormethiazole and permanent middle cerebral artery occlusion in rats. Neurodegeneration 1996;5:81-85.
48. Sydserff SG, Cross AJ, Murray TK, Jones JA, Green AR. Clomethiazole is neuroprotective in models of global and focal cerebral ischemia when infused at doses producing clinically relevant plasma concentrations. Brain Res 2000;862:59-62.
49. Thaminy S, Reymann JM, Heresbach N, Allain H, Lechat P, Bentue-Ferrer D. Is chlormethiazole neuroprotective in experimental global cerebral ischemia? A microdialysis and behavioral study. Pharmacol Biochem Behav 1997;56(4):737-745.
50. Wahlgren NG, Diez-Tejedor E, Teitelbaum J, et al. Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clomethiazole versus placebo in acute stroke patients. Stroke 2000;31:82-85.
51. Wahlgren NG, Ranasinha KW, Rosolacci T, et al. Clomethiazole acute stroke study (CLASS): Results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients. Stroke 1999;30:21-28.
52. Zingmark PH, Ekblom M, Odergren T, et al. Population pharmacokinetics of clomethiazole and its effect on the natural course of sedation in acute stroke patients. Br J Clin Pharmacol 2003;56(2):173-183.